Search

Author/Creator Chotard, Guillaume

1. An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect. Issue 1 (1st March 2022)

Authors:
Rahal, Farah; Capdevielle, Caroline; Rousseau, Benoit; Izotte, Julien; Dupuy, Jean-William; Cappellen, David; Chotard, Guillaume; Ménard, Mélissa; Charpentier, Justine; Jecko, Vincent; Caumont, Charline; Gimbert, Edouard; Grosset, Christophe F; Hagedorn, Martin
Journal:
Neuro-oncology advances
Issue:
Volume 4:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours. (23rd March 2022)

Authors:
Appay, Romain; Bielle, Franck; Sievers, Philipp; Barets, Doriane; Fina, Frédéric; Boutonnat, Jean; Adam, Clovis; Gauchotte, Guillaume; Godfraind, Catherine; Lhermitte, Benoît; Maurage, Claude‐Alain; Meyronet, David; Mokhtari, Karima; Rousseau, Audrey; Tauziède‐Espariat, Arnault; Tortel, Marie‐Cla...
Journal:
Neuropathology & applied neurobiology
Issue:
Volume 48:Number 5(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search